Contract analysis

I. PURPOSE AND SCOPE Langford Moss & Crane LLP ("LMC") has been engaged by Calderwood & Harkness LLP ("C&H") (C&H Matter No. 0478231.0001) on behalf of Ardent Capital Partners III LP ("Ardent Capital" or the "Sponsor") and Ardent Healthcare Holdings Inc. (the "Purchaser") in connection with the proposed acquisition (the "Transaction") of one hundred percent (100%) of the outstanding equity interests of MedVance Healt

1. State Licensure and Certificate-of-Need ("CON") Status. Review of the validity, currency, and good standing of all state healthcare facility licenses and permits held by MedVance, and the status of any CON approvals applicable to MedVance's facilities and services. Assessment of the licensure transfer and CON transfer requirements triggered by the Transaction in each of the four operating states.

2. Federal Fraud and Abuse Laws. Analysis of MedVance's compliance with the federal Physician Self-Referral Law (commonly known as the "Stark Law"), codified at 42 U.S.C. § 1395nn and its implementing regulations at 42 C.F.R. Part 411, and the federal Anti-Kickback Statute ("AKS"), codified at 42 U.S.C. § 1320a-7b(b) and its implementing regulations at 42 C.F.R. Part 1001. This analysis encompasses physician compensa

3. HIPAA Privacy and Security Compliance. Review of MedVance's compliance posture under the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health ("HITECH") Act, and the implementing regulations at 45 C.F.R. Parts 160 and 164, including the Privacy Rule, Security Rule, and Breach Notification Rule.

4. Medicare and Medicaid Enrollment and Participation. Confirmation of current Medicare and Medicaid enrollment status for all MedVance facilities and assessment of the change-of-ownership ("CHOW") filing requirements applicable to the Transaction under federal and state program rules.

5. Other Regulatory Considerations. Review of compliance with the Emergency Medical Treatment and Labor Act ("EMTALA"), Medicare Conditions of Participation, state survey and accreditation history, state-level fraud and abuse statutes, and excluded persons screening protocols. In conducting this review, LMC has examined and relied upon the following categories of materials and information: • Data Room Documents. All

II. EXECUTIVE SUMMARY AND KEY FINDINGS Overall Assessment. Based on our review of the diligence materials and management interviews described above, LMC concludes that MedVance maintains a generally compliant healthcare regulatory posture. We have not identified any material violations of applicable healthcare laws or regulations that would, in our judgment, preclude the consummation of the Transaction or constitute

III. STATE LICENSURE AND CERTIFICATE-OF-NEED COMPLIANCE A. Overview of MedVance's Facility Footprint MedVance Health Systems, Inc. was founded in 2009 by Dr. Catherine Ryland, who currently serves as Founder and Chair of the Board of Directors. Since its founding, MedVance has grown through a combination of organic development and targeted acquisitions to operate a portfolio of healthcare facilities across four south

IV. FEDERAL FRAUD AND ABUSE COMPLIANCE A. Physician Self-Referral Law (Stark Law — 42 U.S.C. § 1395nn) Overview of Stark Law Applicability. The federal Physician Self-Referral Law, commonly known as the "Stark Law," prohibits a physician from making referrals for certain "designated health services" ("DHS") payable by Medicare (or Medicaid, where applicable) to an entity with which the physician (or an immediate fami

V. HIPAA PRIVACY AND SECURITY COMPLIANCE A. HIPAA Privacy Rule (45 C.F.R. Parts 160, 164, Subparts A and E) Covered Entity Status. MedVance Health Systems, Inc. is a "covered entity" under HIPAA as a healthcare provider that conducts standard electronic transactions (e.g., electronic claims submission to Medicare and Medicaid). All of MedVance's nine facilities operate under the corporate entity's single covered enti